Why is High Tide stock sliding today?

High Tide stock is experiencing a decline of 5.4%, trading at C$3.49 following the release of the company's impressive third-quarter fiscal 2026 earnings. The earnings report, announced after market close on September 14, showcased exceptional performance, with revenue hitting C$199 million, surpassing analyst expectations by 45% and growing 33% year over year.

Adjusted EBITDA also reached a record C$16.2 million, marking the highest margin in a dozen quarters, while net income and adjusted earnings per share both set new records. Despite the magnitude of the beat, the stock opened at its session high of C$3.70 and quickly began retreating, a pattern typical of a "sell the news" scenario where positive results had already influenced the share price prior to the announcement.

Canaccord Genuity maintained its Buy rating and C$7.50 price target, highlighting operating leverage and the strength of Remexian, the German medical cannabis subsidiary, as growth drivers. However, the selling pressure is challenging this support, even during today's earnings call webcast. The market environment, with the S&P 500, Nasdaq, and Dow Jones all trading lower today, is adding to the weakness for higher-beta, small-cap names like High Tide.

Currently trading at C$3.49, the stock is significantly below its 52-week high of C$5.59, reflecting the persistent valuation discount applied to Canadian cannabis retailers amid sector-wide concerns over consumer spending and same-store sales challenges.